Brief: Aurinia Board Of Directors Announces Exploration Of Strategic Alternatives To Maximize Shareholder Value
Aurinia Pharmaceuticals Inc AUPH.O :
* AURINIA BOARD OF DIRECTORS ANNOUNCES EXPLORATION OF
STRATEGIC
ALTERNATIVES TO MAXIMIZE SHAREHOLDER VALUE
* AURINIA PHARMACEUTICALS INC - HAS ACCEPTED RECENT DIRECTOR
RESIGNATIONS AND HAS INITIATED A SEARCH FOR NEW DIRECTORS
* AURINIA PHARMACEUTICALS - BOARD TO CONSIDER RANGE OF
OPTIONS FOR
COMPANY INCLUDING, BUT NOT LIMITED TO, A POTENTIAL SALE, MERGER
OR OTHER OPTIONS
Source text for Eikon: ID:nBwbx9799a
Further company coverage: AUPH.O
Recent news on Aurinia Pharmaceuticals
See all newsBrief: Aurinia Settles Patent Litigation With Teva
Canada's Aurinia Q2 revenue rises on LUPKYNIS sales
Brief: Aurinia Pharmaceuticals Q2 Pretax Profit USD 48.786 Million
Aurinia Pharmaceuticals Inc expected to post earnings of 24 cents a share - Earnings Preview
Brief: Lupkynis Associated With A Statistically Significant 53% Reduction In Risk Of Renal-Related Event Or Death